Drug Chemicals Turn Switches on and off at Wrong Times
February 23, 2010
Natural News
By David Gutierrez
Scientists are increasingly becoming aware of a new mechanism by which pollutants can damage the health of living organisms — epigenetic changes, in which a chemical changes how a gene is expressed.
While some chemicals are toxic (attacking the body’s systems directly) and others are mutagenic (changing the actual code of an organism’s genes), others do not change the way a gene is written, but instead how it acts in the body.
Epigenetic changes “can lead to increased susceptibility to disease,” said Linda S. Birnbaum, director of the National Institute of Environmental Health Sciences and of the National Toxicology Program. “The susceptibility persists long after the exposure is gone, even decades later. Glands, organs, and systems can be permanently altered.”
Epigenetic changes have been identified that increase the risk of Alzheimer’s disease, asthma, breast cancer, prostate cancer, diabetes, heart disease, obesity, learning disabilities, Parkinson’s disease and more.
One example was recently uncovered by researchers at the University of Cincinnati, who conducted a study on children in New York City who had been exposed to high levels of air pollutants in the womb. These children had higher rates of asthma than children who had not had such exposure.
Upon performing genetic tests, the researchers found that all the exposed, asthmatic children had a methyl group molecule attached to the ACSL3 gene, causing it to be less active than normal. None of the unexposed children had this molecule attached to their ACSL3 gene.
Researchers have also found epigenetic changes in children conceived through in-vitro fertilization. They believe that the chemicals used to incubate the fertilized eggs before implantation might cause epigenetic changes that lead to the higher rates of abdominal wall defects and cancers observed in such children.
Like mutations, epigenetic effects can be passed on to a person’s offspring.
“There is a huge potential impact from these exposures, partly because the changes may be inherited across generations,” Birnbaum said. “You may be affected by what your mother and grandmother were exposed to during pregnancy.”
Click here for the full report.
The Kevin Trudeau Show: 2-17-10
Today, Kevin explains why he is in court today and the real reason he didn’t get fair coverage from the mainstream media. Plus, more predictions! You won’t want to miss this vital information!!
Foreclosures Reach 315,000 in January
Corporations Have No Interest In Your Safety
Updates to Mental Health Disorders Manual
Speaking of New Made-Up Disorders…
Anti-Depressant Drugs No More Effective Than Placebos
Household Cleaners May Cause Breast Cancer
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
Click below to hear The Kevin Trudeau Show RIGHT NOW!!!
Vitamin D Virtually Eradicates Cancer
February 9, 2010
Natural News
By Mike Adams
In a gathering of vitamin D researchers recently held in Toronto, Dr. Cedric Garland delivered a blockbuster announcement: Breast cancer can be virtually “eradicated” by raising vitamin D levels.
Vitamin D is “the cure” for breast cancer that the cancer industry ridiculously claims to be searching for. The cure already exists! But the breast cancer industry simply refuses to acknowledge any “cure” that doesn’t involve mammography, chemotherapy or high-profit pharmaceuticals.
Vitamin D is finally gaining some of the recognition it deserves as a miraculous anti-cancer nutrient. It is the solution for cancer prevention. It could save hundreds of thousands of lives each year in the U.S. alone. Even Dr. Andrew Weil recently raised his recommendation of vitamin D to 2,000 IU per day.
This is the vitamin that could destroy the cancer industry and save millions of women from the degrading, harmful cancer “treatments” pushed by conventional medicine. No wonder they don’t want to talk about it! The cancer industry would prefer to keep women ignorant about this vitamin that could save their breasts and their lives.
Below I’m reprinting the full statement from Dr. Cedric Garland following the Vitamin D conference recently held in Toronto.
Statement from Dr. Cedric Garland
Breast cancer is a disease so directly related to vitamin D deficiency that a woman’s risk of contracting the disease can be ‘virtually eradicated’ by elevating her vitamin D status to what vitamin D scientists consider to be natural blood levels.
That’s the message vitamin D pioneer Dr. Cedric Garland delivered in Toronto Tuesday as part of the University of Toronto School of Medicine’s “Diagnosis and Treatment of Vitamin D Deficiency” conference – the largest gathering of vitamin D researchers in North America this year. More than 170 researchers, public health officials and health practitioners gathered at the UT Faculty club for the landmark event.
Garland’s presentation headlined a conference that reviewed many aspects of the emerging vitamin D research field – a booming discipline that has seen more than 3,000 academic papers this calendar year alone, conference organizers said. That makes vitamin D by far the most prolific topic in medicine this year, with work connecting it with risk reduction in two dozen forms of cancer, heart disease, multiple scleroses and many other disorders.
Dr. Reinhold Vieth, Associate Professor in the Department of Laboratory Medicine and Pathobiology at University of Toronto, and Director of the Bone and Mineral Laboratory at Mount Sinai Hospital, organized the event in conjunction with Grassroots Health – an international vitamin D advocacy group founded by breast cancer survivor Carole Baggerly.
Baggerly implored the research group to take action and encourage Canadians to learn more about vitamin D and to raise their vitamin D levels.
An estimated 22,700 women will be diagnosed with breast cancer in 2009, according to the Canadian Cancer Society’s latest figures.
As much as 97 percent of Canadians are vitamin D deficient at some point in the year, according to University of Calgary research – largely due to Canada’s northerly latitudes and weak sun exposure. Sunshine is by far the most abundant source of vitamin D – called ‘The Sunshine Vitamin’ – with salmon and fortified milk being other sources. Vitamin D supplementation helps raise levels for many as well.
Grassroots Health’s “D-action” panel – 30 of the world’s leading researchers on vitamin D and many other vitamin D supporters – recommend 2,000 IU of vitamin D daily and vitamin D blood levels of 100-150 nanomoles-per-liter as measured by a vitamin D blood test.
Vieth pointed out that natural vitamin D levels of mammals who live outdoors in sunny climates is higher than that – up to 200 nanomoles-per liter. And Garland, whose presentation was entitled “Breast Cancer as a Vitamin D Deficiency Disease” presented data showing that raising one’s vitamin D status near those levels decreased breast cancer risk more than 77 percent.
‘The Sunshine Vitamin’ was once thought of only for bone health, helping the body process calcium. But more recent work has shown that all cells in the body have “vitamin D receptors” which help control normal cell growth. Additionally, Garland presented new evidence that low vitamin D status compromises the integrity of calcium-based cellular bonding within tissues, which when eroded allow rogue cancer cells to spread more readily.
Grassroots Health is trying to raise vitamin D awareness among Canadians. Despite epidemic-level vitamin D deficiency in Canada, fewer than nine per cent of Canadians have ever had their vitamin D levels checked by a professional and most who have do not know their vitamin D blood level.
Click here for the full report.
Mango – Preventing Growth of Colon and Breast Cancer Cells
January 21,2010
Natural News
By S. L. Baker
Take a bite of a juicy, sweet mango and you are experiencing a delicious taste enjoyed by countless people from ancient times until today. According to the Orlando-based National Mango Board (NMG), a mango industry-sponsored research, promotion and consumer information program, mangos are known to be rich in vitamins C and A, as well as fiber. However, because little has been documented about any specific health benefits of eating the fruit, NMB has commissioned a variety of scientific studies to investigate these issues.
So far, this research initiative has turned up an unexpected and groundbreaking discovery: in laboratory experiments in Texas A&M University’s AgriLife Research department mango fruit prevented or stopped cancer growth in certain breast and colon cell lines.
Food scientists Dr. Susanne Talcott and her co-researcher husband, Dr. Steve Talcott, used the five varieties of mangos (Kent, Francine, Ataulfo, Tommy/Atkins and Haden) most common in the US and specifically tested polyphenol extracts from the fruit on colon, breast, lung, leukemia and prostate cancer cells. Polyphenols are natural substances in plants that are antioxidants with the potential to protect the body from disease. The Talcotts zeroed in on evaluating polyphenolic compounds in mangos known as gallotannins, a class of natural bioactive compounds believed to help prevent or block the growth of cancer cells.
The results? The Talcotts’ experiments showed that the mango extract demonstrated some cancer fighting ability when tested on lung, leukemia and prostate cancer cells. But when tested on the most common breast and colon cancers, mango compounds were found to have even stronger anticancer abilities. In fact, the mango extract caused the breast and colon cancer cells to undergo apoptosis — programmed cell death.
“Additionally, we found that when we tested normal colon cells side by side with the colon cancer cells, the mango polyphenolics did not harm the normal cells,” Dr. Susanne Talcott said in a statement to the press. “That is a general observation for any natural agent, that they target cancer cells and leave the healthy cells alone, in reasonable concentrations at least.”
The researchers documented that the cancer cell cycle (the division process cells go through) was interrupted by mango extract. This is crucial information, Suzanne Talcott said in a press statement, because it could explain a possible mechanism for how the cancer cells are prevented or stopped by phytochemicals in mangos. “For cells that may be on the verge of mutating or being damaged, mango polyphenolics prevent this kind of damage,” she explained.
The scientists have conducted additional research on the colon cancer cell lines because mangos contain small molecules that are readily absorbed in the colon as well as larger molecules that are not absorbed and remain present longer in the colon. Those facts could potentially make eating mangos a potent way to help prevent colon cancer. In fact, the Talcotts are hoping to next conduct a small clinical trial to see if mangos can prevent colon cancer in people at high risk for a malignancy because they have increased inflammation in their intestines.
Click here to read the full report
Continuing The Question of Breast Cancer Screenings
January 20, 2010
Telegraph.co.uk
By Rebecca Smith
Despite assertions that screening saves 1,400 lives a year, there is no evidence the programme has cut deaths, the article in the Journal of the Royal Society of Medicine said.
Controversy over the benefits of breast cancer screening were first raised last year when experts said women were not being told of the potential harms in leaflets given out to encourage attentance.
Women may be wrongly told they have cancer and so undergo unnecessary treatment and screening may detect tumours that would not progress to be harmful and so could also be removed needlessly. The unnecessary treatments may expose women to chemotherapy, radiotherapy or surgery which itself has harmful effects.
Experts at the Nordic Cochrane Centre has now calculated that 7,000 women in Britain are being wrongly diagnosed with breast cancer as a result of screening.
In 2006 there were 45,400 women and 300 men diagnosed with breast cancer in Britain, according to data held by Cancer Research UK.
Figures from the charity show in the 1970s only five out of 10 patients lived for five years after diagnosis compared with eight out of ten now.
Two authors from the Nordic Cochrane Centre, an independent research centre, evaulated the NHS screening programme’s annual report and said many of its assertions are not backed by the evidence.
Mortality rates for breast cancer began dropping before the screening programme was introduced in 1988 and have dropped just as much in women too young to be called for screening showing that the reduction in deaths is probably due to better treatment and not screening, it said.
Lead author Karsten Juhl Jørgensen said one in five women who have been screened for ten years will have been recalled for some suspect finding on their mammography raising concern they have cancer only to be given the all clear.
Some of those women will have had further testing such as a biopsy taken by inserting a needle into the ‘tumour’ and three per cent will have had surgery.
The article went on to say that women who attend for screening are often more health conscious so their prognosis will be better and screening tends to find cancers that are slow growing and both factors contribute to the idea that women whose cancers are detected via screening have better survival rates.
It said:”Most of the pronounced decline in breast cancer mortality is likely caused by improved treatment, which can explain why it has been similarly large among the young women who have not been invited to screening. Other factors, such as increased ‘breast awareness’, may also have contributed.”
Professor Julietta Patnick, Director of the NHS Cancer Screening Programmes said: “This paper is not based on any new data. The NHS Breast Screening Programme, the independent Advisory Committee on Breast Cancer Screening and numerous independent screening practitioners have all responded previously pointing out the inaccuracies in the author’s selection and use of the statistics on breast screening.
“Numerous independent studies have shown breast cancer screening reduces mortality. A report from the World Health Organisation’s International Agency for Research on Cancer (IARC) concluded that there is a 35 per cent reduction in mortality from breast cancer among regularly screened women aged 50 – 69 years old.
“In the UK the independent Advisory Committee on Breast Cancer Screening estimated that for every 400 women screened regularly by the NHS Breast Screening Programme over a 10 year period, one woman fewer will die from breast cancer than would have died without screening, and the current NHS Breast Screening Programme saves an estimated 1,400 lives each year in England.”
A spokesman for the Department of Health said: “Cancer remains a high priority for this Government. The Cancer Reform Strategy, published in December 2007 sets out a clear direction for cancer services over the next five years and shows how we will deliver cancer outcomes that are amongst the best in the world.
“We know that, generally, the earlier a cancer is diagnosed the greater the chance it will be treated successfully. During 2007/08, the NHS Breast Screening Programme screened over 1.7 million women and 14,110 cancers were detected.”
Click here for the full report.
Ridiculous Story of the Week: ‘Microwaves Help Shrink Breast Cancer Tumours’
January 18, 2010
Visit Bulgaria
By Anna Tomova
Reporting a new advancement in late stage breast cancer treatment, Dr. William Dooley, Director, Surgical Oncology, University of Oklahoma Health Sciences Centre reports, a recent study reveals microwave heating of breast tissue, not only helps shrinks tumours, but also makes chemotherapy more effective.
Earlier, the only treatment for late stage breast cancer was mastectomy, however, women now have a better chance of surviving breast cancer and do not have to have their breasts removes, as figures from the initial study indicate, this new technology may reduce the need for a mastectomy by 90%.
It is not known yet, why the cancer cells are so sensitive to microwave generated heat, and Dr. Dooley is of the opinion that this treatment will not work on other cancer types.
Researchers have for long been trying to find a treatment for breast cancer that does not involve mastectomy, as body image and self confidence are important in helping a patient heal fully, after going through with this horrible ordeal.
Already, researchers have begun to plan the next phase of clinical trials this year for testing the therapy on even larger tumours.
Click here for the full report.
Why Beer Is The Latest Hope In Fight Against Cancer
January 18, 2010
DailyMail.co.uk
By Anastasia Stephens
It might be your preference to crack open a bottle of red wine at the end of a hard day but you may be better off pouring a pint.
Researchers at the German Cancer Research Centre in Heidelberg have discovered that beer contains a powerful molecule that helps protect against breast and prostate cancers.
Found in hops, the substance called xanthohumol blocks the excessive action of testosterone and oestrogen. It also helps to prevent the release of a protein called PSA which encourages the spread of prostate cancer.
Scientists have long known that substances in hops help to block oestrogen. This is the first time, however, that they have been found to also inhibit testosterone.
‘Research is still early but in trials we hope to further demonstrate that xanthohumol actively prevents prostate cancer development,’ says Clarissa Gerhauser of the Heidelberg centre. If successful, xanthohumol may one day be developed as a cancer-fighting drug.
So which brews are likely to be richest in xanthohumol?
‘Hops give beer its bitter flavour, so traditional bitters and ales will contain far more of this substance than light lagers,’ explains Ben McFarland, author of the World’s Best Beers.
Beers highest in hops, he says, are India pale ales such as those made by the Meantime Brewery in Greenwich, South-East London. First brewed in the 1800s, these ales were made with high levels of hops to act as a natural preservative for export.
Ales such as Sharp’s and local bitters will also be hop-rich, containing around three to four times more than a typical light lager. Drinks such as Guinness owe their dark colour to malt and contain moderate levels of hops.
Alcohol Concern warns you should only drink beer within recommended limits – two to three units a day for women, three to four units for men.
Click here for the full report.
Pomegranate Helping Prevent Breast Cancer
January 13, 2010
Reuters
By Xavier Briand
An acid found in pomegranates appears to block aromatase, an enzyme that converts androgen to estrogen, a hormone that plays a role in the development of breast cancer, the researchers wrote in the journal Cancer Prevention Research.
“We identified some of these chemicals in pomegranates that actually have properties that can suppress aromatase,” researcher Shiuan Chen, of the City of Hope cancer research and treatment center in Duarte, California, said in a telephone interview.
Many women who have had breast cancer take medicines called aromatase inhibitors — such as Pfizer’s Aromasin, Novartis’ Femara and AstraZeneca Plc’s Arimidex — to keep estrogen from feeding tumors.
Chen and colleagues studied whether compounds, or phytochemicals, in pomegranates can suppress aromatase and ultimately block cancer growth. They found that 10 natural compounds in the fruit may potentially prevent estrogen-related breast cancer.
Chen said the compounds would not be a replacement for aromatase inhibitors.
“We do not recommend people start taking this as a replacement for the AI’s,” Chen said. “They (pomegranate compounds) are not as potent as the real drugs so we think that the interest probably is more on the prevention end rather than in a therapeutic purpose.”
Other researchers not associated with the study told the journal that the results are promising, and suggested more studies involving animals and humans were needed to confirm the findings.
“It’s not clear that these levels could be achieved in animals or in humans because the (compounds) are not well absorbed into blood when provided in the diet,” said Gary Stoner of Ohio State University.
Dr. Powel Brown, an oncologist at the University of Texas, said in a statement that future studies should focus on testing pomegranate juice for its effect on estrogen levels, menopausal symptoms, breast density or even as a cancer preventive agent.
More than 400,000 women die from breast cancer globally every year. About 75 percent of breast cancers are estrogen-receptor positive, meaning they are fed by estrogen.
Previous research has shown that pomegranate juice is rich in antioxidants — vitamins and other substances — that may help prevent diseases such as cancer, heart disease and Alzheimer’s disease.
Pomegranate Reduces Risks of Breast Cancer
January 8, 2010
Reuters
By Xavier Briand
An acid found in pomegranates appears to block aromatase, an enzyme that converts androgen to estrogen, a hormone that plays a role in the development of breast cancer, the researchers wrote in the journal Cancer Prevention Research.
“We identified some of these chemicals in pomegranates that actually have properties that can suppress aromatase,” researcher Shiuan Chen, of the City of Hope cancer research and treatment center in Duarte, California, said in a telephone interview.
Many women who have had breast cancer take medicines called aromatase inhibitors — such as Pfizer’s Aromasin, Novartis’ Femara and AstraZeneca Plc’s Arimidex — to keep estrogen from feeding tumors.
Chen and colleagues studied whether compounds, or phytochemicals, in pomegranates can suppress aromatase and ultimately block cancer growth. They found that 10 natural compounds in the fruit may potentially prevent estrogen-related breast cancer.
Chen said the compounds would not be a replacement for aromatase inhibitors.
“We do not recommend people start taking this as a replacement for the AI’s,” Chen said. “They (pomegranate compounds) are not as potent as the real drugs so we think that the interest probably is more on the prevention end rather than in a therapeutic purpose.”
Other researchers not associated with the study told the journal that the results are promising, and suggested more studies involving animals and humans were needed to confirm the findings.
“It’s not clear that these levels could be achieved in animals or in humans because the (compounds) are not well absorbed into blood when provided in the diet,” said Gary Stoner of Ohio State University.
Dr. Powel Brown, an oncologist at the University of Texas, said in a statement that future studies should focus on testing pomegranate juice for its effect on estrogen levels, menopausal symptoms, breast density or even as a cancer preventive agent.
More than 400,000 women die from breast cancer globally every year. About 75 percent of breast cancers are estrogen-receptor positive, meaning they are fed by estrogen.
Previous research has shown that pomegranate juice is rich in antioxidants — vitamins and other substances — that may help prevent diseases such as cancer, heart disease and Alzheimer’s disease.
Click here for the full report
Eating Pomegranates Reduces Risk of Breast Cancer
January 06, 2010
Reuters
By Xavier Briand
An acid found in pomegranates appears to block aromatase, an enzyme that converts androgen to estrogen, a hormone that plays a role in the development of breast cancer, the researchers wrote in the journal Cancer Prevention Research.
“We identified some of these chemicals in pomegranates that actually have properties that can suppress aromatase,” researcher Shiuan Chen, of the City of Hope cancer research and treatment center in Duarte, California, said in a telephone interview.
Many women who have had breast cancer take medicines called aromatase inhibitors — such as Pfizer’s Aromasin, Novartis’ Femara and AstraZeneca Plc’s Arimidex — to keep estrogen from feeding tumors.
Chen and colleagues studied whether compounds, or phytochemicals, in pomegranates can suppress aromatase and ultimately block cancer growth. They found that 10 natural compounds in the fruit may potentially prevent estrogen-related breast cancer.
Chen said the compounds would not be a replacement for aromatase inhibitors.
“We do not recommend people start taking this as a replacement for the AI’s,” Chen said. “They (pomegranate compounds) are not as potent as the real drugs so we think that the interest probably is more on the prevention end rather than in a therapeutic purpose.”
Other researchers not associated with the study told the journal that the results are promising, and suggested more studies involving animals and humans were needed to confirm the findings.
“It’s not clear that these levels could be achieved in animals or in humans because the (compounds) are not well absorbed into blood when provided in the diet,” said Gary Stoner of Ohio State University.
Dr. Powel Brown, an oncologist at the University of Texas, said in a statement that future studies should focus on testing pomegranate juice for its effect on estrogen levels, menopausal symptoms, breast density or even as a cancer preventive agent.
More than 400,000 women die from breast cancer globally every year. About 75 percent of breast cancers are estrogen-receptor positive, meaning they are fed by estrogen.
Previous research has shown that pomegranate juice is rich in antioxidants — vitamins and other substances — that may help prevent diseases such as cancer, heart disease and Alzheimer’s disease.
